Plasma Bile Acid Concentrations in Humans: Suggestions for Presentation in Tabular Form
Alan F. Hofmann, Hanns‐Ulrich Marschall – 31 March 2018
Biliary Atresia: Clinical and Research Challenges for the Twenty‐First Century
Jorge A. Bezerra, Rebecca G. Wells, Cara L. Mack, Saul J. Karpen, Jay H. Hoofnagle, Edward Doo, Ronald J. Sokol – 31 March 2018 – Biliary atresia (BA) is a fibroinflammatory disease of the intrahepatic and extrahepatic biliary tree. Surgical hepatic portoenterostomy (HPE) may restore bile drainage, but progression of the intrahepatic disease results in complications of portal hypertension and advanced cirrhosis in most children.
Receipt of a pediatric liver offer as the first offer reduces waitlist mortality for adult women
Jin Ge, Richard Gilroy, Jennifer C. Lai – 31 March 2018 – In liver transplantation, adults with small stature have a greater susceptibility to waitlist mortality. This may explain the persistent waitlist mortality disparity that exists for women. We hypothesized that women who receive early offers of pediatric donor livers have improved waitlist survival, and that preferentially offering these organs to women mitigates this sex‐based disparity. We analyzed donor liver offers from 2010 to 2014.
Role of Sarcopenia in Nonalcoholic Fatty Liver Disease: Definition Is Crucially Important
Tao‐Chun Peng – 31 March 2018
Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation
Dagmar Kollmann, Gonzalo Sapisochin, Nicolas Goldaracena, Bettina E. Hansen, Ramraj Rajakumar, Nazia Selzner, Mamatha Bhat, Stuart McCluskey, Mark S. Cattral, Paul D. Greig, Les Lilly, Ian D. McGilvray, Anand Ghanekar, David R. Grant, Markus Selzner – 31 March 2018 – Because of the shortfall between the number of patients listed for liver transplantation (LT) and the available grafts, strategies to expand the donor pool have been developed.
Reply
Min Suk Chae, Sang Hyun Hong – 31 March 2018
Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with hazard associated with liver transplantation for HCC (HALTHCC) improves ablate and wait strategy
Daniel J. Firl, Shoko Kimura, John McVey, Koji Hashimoto, Heidi Yeh, Charles M. Miller, James F. Markmann, Kazunari Sasaki, Federico N. Aucejo – 31 March 2018 – Patients with hepatocellular carcinoma (HCC) are screened at presentation for appropriateness of liver transplantation (LT) using morphometric criteria, which poorly specifies risk. Morphology is the crux of measuring tumor response to locoregional therapy (LRT) using modified Response Evaluation Criteria in Solid Tumors (mRECIST).
Reply
Rahima A. Bhanji, Kymberly D. Watt – 31 March 2018
Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes‐like approach?
Stergios A. Polyzos, Jannis Kountouras, Sotiris Anastasiadis, Michael Doulberis, Panagiotis Katsinelos – 30 March 2018
Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis
Audrey Payancé, Gilberto Silva‐Junior, Julien Bissonnette, Marion Tanguy, Blandine Pasquet, Cristina Levi, Olivier Roux, Ouardia Nekachtali, Anna Baiges, Virginia Hernández‐Gea, Cédric Laouénan, Didier Lebrec, Miguel Albuquerque, Valérie Paradis, Richard Moreau, Dominique Valla, François Durand, Chantal M. Boulanger, Juan‐Carlos Garcia‐Pagan, Pierre‐Emmanuel Rautou – 30 March 2018 – Microvesicles (MVs) are extracellular vesicles released by cells following activation or apoptosis. Some MV subpopulations augment with cirrhosis severity and contribute to portal hypertension.